The name of the most successful #prescription drug to be launched in 2022 should come as no surprise to anyone who reads People Magazine. 💫 Dozens of celebrities – Oprah Winfrey, Amy Schumer, Whoopi Goldberg, Charles Barkley, Rosie O’Donnell, Elon Musk, and many others – have admitted to using #Mounjaro or its GLP-1 agonist cousin #Ozempic to help control their weight, pushing the brands from the pharmacy to the tabloids and helping Mounjaro earn more than $5 billion in sales in its first full year on the market, good enough for second in Eli Lilly’s entire portfolio. For pharma’s launch class of 2022, it would seem, weight loss is the new black. Read more of Joshua Slatko's analysis in "First year after launch: an extra-pharma phenomenom." https://lnkd.in/eqWEMUZp #MedAdNews
Med Ad News’ Post
More Relevant Posts
-
20 Years+ International Learning & Development Expert I Business Consultant I Edutech & Digital Education Advocate I Sustainability in Education in UAE Award 🥇
Integrative Leadership " Case study "- River Blindness & Merck CEO : Back in the 1970s, River Blindness was among the most feared diseases in the world, and scientists had long been frustrated in their efforts to stop the spread of the disease in developing nations. Then, researchers at Merck discovered a potential cure for river blindness. The drug would cost over $200 million to create, and it would only be available to those who could afford it. When Merck's CEO (Roy Vagelos) was unable to get the governments of developing countries to agree to the drug's development, it became clear that the drug would never be profitable for Merck, but Vagelos chose to distribute it free to the people whose lives it would save. Many within the company argued that this was a costly error that violated the CEO's fiduciary duty to the company's stockholders. Vagelos, however, believed that this decision was in line with Merck's guiding mission of preserving and improving human life. This humanitarian decision helped to almost completely eliminate River Blindness. It also helped Merck's reputation and attracted some of the world's best medical minds. #business #Coaching #enterprenuership #leadershipmastery #leadership #sararamadan #businesscasestudy #integrativeleadership #leadershipinorganization
-
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> BIO's new CEO takes a patriotic pivot to win back Congress, pushing industry to rethink China relationship >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #pharmaceutical #pharma #productmarketing
-
Dive into the art of making pivotal decisions in early drug discovery! Join us for an exclusive webinar with the authors of 'Making Good Decisions in Early Drug Discovery' featured in Nature Journal June, 2024. Discover the power of Decision Framing and how it can guide your team towards innovative strategies in the face of uncertainties. Don’t just make decisions—make the right ones. Register now: https://lnkd.in/eaiqBm4i #DecisionFrameworks #DrugDiscovery #StrategicDecisionMaking #Webinar
-
-
It’s our 100th episode!! 🎉 To celebrate we have picked three technologies that are receiving traction right now - #FemTech #BatteryTech #Dementia - and are joined by AstraZeneca consultant, Stasa Stankovic; Dr. Simon Engelke, Founder and Chair of Battery Associates; and Andrew Kadis, Cambridge Vision Technology. Tune in to find out more about why the media is so interested in these areas. #CamTechPod
-
-
Ready for a new dose of knowledge? 🧐 Check out this episode of the #NoJargon series where Sanofi #scientists explain what a #MonoclonalAntibody is in simple terms. Mission accomplished?
-
Ready for a new dose of knowledge? 🧐 Check out this episode of the #NoJargon series where Sanofi #scientists explain what a #MonoclonalAntibody is in simple terms. Mission accomplished?
-
It’s coming folks, if you want to wait and see what happens, “feel it out”, that’s fine..but change is coming, and it’s change for the better. Your employees are paying attention now. If you are ready to start building benefit plans that are about best drug for best price possible today..let’s go! Mark Cuban Cost Plus Drug Company, PBC #transparency SmithRx
Watch CNBC's full interview with billionaire investor Mark Cuban
cnbc.com
-
During my undergraduate studies, I aimed to work in the biotech 💉 industry. Since pivoting into the legal ⚖ practice, I'm all-the-more happy to have landed at Fenwick & West, which has a dual-focus on both the general tech sector and the life sciences sector. This duality has shaped my own patent prosecution practice with a core focus on the overlap of machine-learning techniques as applied to biotech research & development. 🏆 🎉 #LifeSciences #Healthtech #PGOTY
In recognition of Fenwick’s remarkable life sciences impact, Law360 named us among its life sciences Practice Groups of the Year for 2023. Raising hundreds of millions in capital, guiding pivotal industry collaborations, protecting groundbreaking IP, and breathing life into a sluggish year for M&A with blockbuster deals including DICE Therapeutics’ $2.4 billion acquisition by Eli Lilly and Company and Chinook Therapeutics’ $3.5 billion sale to Novartis—all of it resonated through the legal industry. From inception to market leaders, Fenwick assists life sciences companies at every stage of their lifecycle with a broad array of services and a holistic approach that supports growth. Learn more: https://bit.ly/3vIOLEK #LifeSciences #Innovation #Awards
-
Practice Area Specialist/Research Attorney at LexisNexis--Curiosity promoter, skill builder and life-long learner
Fantastic! And where can you read about this? On Law360 on LexisNexis!
In recognition of Fenwick’s remarkable life sciences impact, Law360 named us among its life sciences Practice Groups of the Year for 2023. Raising hundreds of millions in capital, guiding pivotal industry collaborations, protecting groundbreaking IP, and breathing life into a sluggish year for M&A with blockbuster deals including DICE Therapeutics’ $2.4 billion acquisition by Eli Lilly and Company and Chinook Therapeutics’ $3.5 billion sale to Novartis—all of it resonated through the legal industry. From inception to market leaders, Fenwick assists life sciences companies at every stage of their lifecycle with a broad array of services and a holistic approach that supports growth. Learn more: https://bit.ly/3vIOLEK #LifeSciences #Innovation #Awards
-
Project Director | IPMA PM of the Year (Gold) | Renewable Energy | Content Creator
2024-04-13 AsSalam... In our pursuit of success, we often encounter a culture fixated on the negative, where mistakes are met with penalties rather than seen as stepping stones for growth. The reality is that understanding what doesn’t work is a hidden gem of knowledge, essential for paving the way to what will work. #GrowthMindset #PositiveCulture #LearningFromFailure #Leadership #Management #EmployeeRecognition #ConsequenceManagement #BalancingAct Let's shift the focus from penalizing to recognizing, understanding that every error addressed correctly is an investment in our collective wisdom. Recognition should echo louder than reprimand. After all, the brightest diamonds are created under pressure. 😉🤔🎉🚀🚆🤝
Prof @ Harvard Business School; Author of "Right Kind of Wrong: The Science of Failing Well"
Failure parties were popularized by Eli Lilly as a way to show appreciation for pioneering teams that failed intelligently—that is, they failed while pursuing a defined goal in new territory, and their failure brought valuable new information to the company that couldn't have been gained any other way. Not only did these parties show appreciation and help the scientists cope with their disappointment, but they also ensured that others in the department learned about the failure to prevent repeating it—another best practice for keeping the costs of failure as small as possible. While not all failures warrant a celebration, #IntelligentFailure is definitely worthy. As Dr. David Burkus said in his wonderful post (linked below): "Instead of shaking our fists at the sky, shake up a cocktail instead." 🥳 https://lnkd.in/ecRzRSxf
-
